109
Views
4
CrossRef citations to date
0
Altmetric
Review

Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome

&
Pages 361-374 | Published online: 27 Oct 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Yukiko Handa, Shinya Fukushima, Shogen Yo, Motoyasu Osawa, Takahisa Murao, Osamu Handa, Hiroshi Matsumoto, Eiji Umegaki & Akiko Shiotani. (2021) Evaluation of efficacy and safety of lubiprostone in patients with chronic constipation. Scandinavian Journal of Gastroenterology 56:10, pages 1140-1145.
Read now
Hiroyuki Ohbayashi, Yasuo Sato, Mari Kiuchi, Takamitsu Asano, Atsushi Nagazumi & Takazumi Kimura. (2021) Open-label study to evaluate the treatment continuation rate after a dose reduction of lubiprostone due to onset of adverse events. Expert Review of Gastroenterology & Hepatology 15:3, pages 333-342.
Read now
Maria Vazquez Roque & Michael Camilleri. (2011) Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation. Expert Review of Gastroenterology & Hepatology 5:3, pages 301-310.
Read now

Articles from other publishers (1)

Ulrike Voß, Anne Lewerenz & Karen Nieber. 2012. Sex and Gender Differences in Pharmacology. Sex and Gender Differences in Pharmacology 473 497 .